The drugs treat disorders such as anxiety, panic attacks and insomnia, but stopping them abruptly can compound users’ symptoms and even endanger their lives.
Category: Drugs (Pharmaceuticals)
-
Trump Signs Executive Order Asking Companies to Lower Drug Prices
The president has long complained that the United States pays more for medicines than other wealthy countries. But he offered no clear legal authority to mandate lower prices.
-
Trump Plan Would Tie Some Drug Prices to What Peer Nations Pay
The president announced an executive order aimed at lowering U.S. drug costs, revisiting an idea that was blocked in court during his first term.
-
Trump Plan Would Tie Some Drug Prices to What Peer Nations Pay
The president announced an executive order aimed at lowering U.S. drug costs, revisiting an idea that was blocked in court during his first term.
-
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.
-
WeightWatchers Files for Bankruptcy to Reduce $1 Billion in Debt
The company, which has shaped how millions eat and exercise, is trying to reduce its debt as it expands its telehealth business.
-
Chinese Imports to US Hit 20-Year Low as Tariffs Sink In
While imports can swing with seasonal shifts, President Trump’s ratcheting up of U.S. tariffs on China has begun to cascade through supply chains, government data shows.
-
Kennedy Issues Demands for Vaccine Approvals that Could Affect Fall Covid Boosters
The agency suggested that clinical trials in humans may be required for updated Covid shots, raising questions about whether they will be available in the fall.
-
Europe’s Pharma Industry Braces for Pain as Trump Tariff Threat Looms
Medicines and chemicals are huge exports for European Union countries. That makes the sector a weak spot as trade tensions drag on.
-
Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar
Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.
-
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.
-
Trump Seeks to Lower Drug Prices Through Medicare and Some Imports
President Trump directed his administration to help states import drugs from Canada. But a proposal to alter a Medicare program to reduce costs could wind up raising prices.